Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Rehabilitation of the hemiparetic gait by nociceptive withdrawal reflex-based functional electrical therapy: a randomized, single-blinded study.

Spaich EG, Svaneborg N, Jørgensen HR, Andersen OK.

J Neuroeng Rehabil. 2014 May 7;11:81. doi: 10.1186/1743-0003-11-81.

2.

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, Thijs V, Berge E; SCAST Study Group.

Lancet. 2011 Feb 26;377(9767):741-50. doi: 10.1016/S0140-6736(11)60104-9.

PMID:
21316752
3.

Patients' perceptions of the benefits and problems of using the ActiGait implanted drop-foot stimulator.

Burridge JH, Haugland M, Larsen B, Svaneborg N, Iversen HK, Christensen PB, Pickering RM, Sinkjaer T.

J Rehabil Med. 2008 Nov;40(10):873-5. doi: 10.2340/16501977-0268.

4.

Phase II trial to evaluate the ActiGait implanted drop-foot stimulator in established hemiplegia.

Burridge JH, Haugland M, Larsen B, Pickering RM, Svaneborg N, Iversen HK, Christensen PB, Haase J, Brennum J, Sinkjaer T.

J Rehabil Med. 2007 Apr;39(3):212-8.

5.

The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids.

Svaneborg N, Kristensen SD, Hansen LM, Büllow I, Husted SE, Schmidt EB.

Thromb Res. 2002 Feb 15;105(4):311-6.

PMID:
12031825
6.

The effect of n-3 fatty acids on neutrophil chemiluminescence.

Varming K, Schmidt EB, Svaneborg N, Møller JM, Lervang HH, Grunnet N, Jersild C, Dyerberg J.

Scand J Clin Lab Invest. 1995 Feb;55(1):47-52.

PMID:
7624736
7.

The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects.

Svaneborg N, Møller JM, Schmidt EB, Varming K, Lervang HH, Dyerberg J.

Lipids. 1994 Feb;29(2):145-7.

PMID:
8152348
8.

The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease.

Lervang HH, Schmidt EB, Møller J, Svaneborg N, Varming K, Madsen PH, Dyerberg J.

Scand J Clin Lab Invest. 1993 Jul;53(4):417-23.

PMID:
8378746
9.

The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis.

Møller JM, Svaneborg N, Lervang HH, Varming K, Madsen P, Dyerberg J, Schmidt EB.

Thromb Res. 1992 Sep 1;67(5):569-77.

PMID:
1448789
10.

Supplemental Content

Loading ...
Support Center